Healico-Praz Capsule SR is a combination pharmaceutical formulation containing Domperidone 30 mg and Rabeprazole 20 mg, designed for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying. Rabeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. The sustained-release (SR) formulation ensures prolonged therapeutic plasma concentrations, enhancing efficacy and improving patient compliance by reducing dosing frequency. Healico-Praz is indicated for the treatment of acid peptic disorders accompanied by motility disturbances, including GERD with associated dyspepsia and gastroparesis. It is contraindicated in patients with known hypersensitivity to either component, and caution is advised in those with hepatic or renal impairment. Common adverse effects may include headache, dry mouth, abdominal cramps, and diarrhea. Healico-Praz Capsule SR should be used under medical supervision, with dosage adjustments based on clinical response and tolerability.